These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 35269942)

  • 1. Role of Nuclear Receptors in Controlling Erythropoiesis.
    Pastori V; Pozzi S; Labedz A; Ahmed S; Ronchi AE
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of the repertoire of nuclear receptor binding sites in genomes.
    Cotnoir-White D; Laperrière D; Mader S
    Mol Cell Endocrinol; 2011 Mar; 334(1-2):76-82. PubMed ID: 21056084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear receptor: Structure and function.
    Sar P
    Prog Mol Biol Transl Sci; 2023; 196():209-227. PubMed ID: 36813359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nuclear receptor superfamily: A structural perspective.
    Weikum ER; Liu X; Ortlund EA
    Protein Sci; 2018 Nov; 27(11):1876-1892. PubMed ID: 30109749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship of nuclear receptor-ligand interactions.
    Greschik H; Moras D
    Curr Top Med Chem; 2003; 3(14):1573-99. PubMed ID: 14683516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent ligands of nuclear receptors.
    Rajan S; Yoon HS
    Eur J Med Chem; 2023 Dec; 261():115869. PubMed ID: 37857142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of nuclear receptors in the modulation of insulin secretion in lipid-induced insulin resistance.
    Sugden MC; Holness MJ
    Biochem Soc Trans; 2008 Oct; 36(Pt 5):891-900. PubMed ID: 18793157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functions of Nutrient-Sensing Nuclear Receptors in Health.
    Yamaji R
    J Nutr Sci Vitaminol (Tokyo); 2022; 68(Supplement):S14-S16. PubMed ID: 36436998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023.
    Burris TP; de Vera IMS; Cote I; Flaveny CA; Wanninayake US; Chatterjee A; Walker JK; Steinauer N; Zhang J; Coons LA; Korach KS; Cain DW; Hollenberg AN; Webb P; Forrest D; Jetten AM; Edwards DP; Grimm SL; Hartig S; Lange CA; Richer JK; Sartorius CA; Tetel M; Billon C; Elgendy B; Hegazy L; Griffett K; Peinetti N; Burnstein KL; Hughes TS; Sitaula S; Stayrook KR; Culver A; Murray MH; Finck BN; Cidlowski JA
    Pharmacol Rev; 2023 Nov; 75(6):1233-1318. PubMed ID: 37586884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of nuclear receptor-coregulator recognition.
    Savkur RS; Bramlett KS; Clawson D; Burris TP
    Vitam Horm; 2004; 68():145-83. PubMed ID: 15193454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DAX1-unusual member of nuclear receptors superfamily with diverse functions].
    Orekhova AS; Rubtsov PM
    Mol Biol (Mosk); 2015; 49(1):75-88. PubMed ID: 25916112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of a novel subfamily of nuclear receptors with members that each contain two DNA binding domains.
    Wu W; Niles EG; Hirai H; LoVerde PT
    BMC Evol Biol; 2007 Feb; 7():27. PubMed ID: 17319953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of nuclear receptors: Novelty and therapeutic implications.
    Shindo S; Kakizaki S; Sakaki T; Kawasaki Y; Sakuma T; Negishi M; Shizu R
    Pharmacol Ther; 2023 Aug; 248():108477. PubMed ID: 37330113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of xenobiotic receptors by steroids.
    Banerjee M; Robbins D; Chen T
    Molecules; 2013 Jun; 18(7):7389-406. PubMed ID: 23884115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthetic ligands for nuclear receptors].
    Kato S
    Nihon Rinsho; 2010 Oct; 68(10):1830-4. PubMed ID: 20954325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors.
    Wang Z; Benoit G; Liu J; Prasad S; Aarnisalo P; Liu X; Xu H; Walker NP; Perlmann T
    Nature; 2003 May; 423(6939):555-60. PubMed ID: 12774125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Nuclear Receptors with PROTAC degraders.
    Flanagan JJ; Neklesa TK
    Mol Cell Endocrinol; 2019 Aug; 493():110452. PubMed ID: 31125586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A signature motif in transcriptional co-activators mediates binding to nuclear receptors.
    Heery DM; Kalkhoven E; Hoare S; Parker MG
    Nature; 1997 Jun; 387(6634):733-6. PubMed ID: 9192902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear receptors as drug targets: new developments in coregulators, orphan receptors and major therapeutic areas.
    Sladek FM
    Expert Opin Ther Targets; 2003 Oct; 7(5):679-84. PubMed ID: 14498828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains.
    Renaud JP; Harris JM; Downes M; Burke LJ; Muscat GE
    Mol Endocrinol; 2000 May; 14(5):700-17. PubMed ID: 10809233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.